Background: Applying peripheral venous lactate instead of arterial lactate in clinical practice is questionable because of deviation between both values. We aimed to find the relationship between the arterial lactate and the peripheral venous lactate before reasoned that the venous lactate could be used in substitution to the arterial lactate in sepsis. Methods: We conducted a prospective, cross-sectional study at a university hospital. The patients with sepsis in ICU who required lactate level monitoring were enrolled in this research. The correlation and agreement between arterial lactate (A-LACT) and peripheral venous lactate (V-LACT) were the primary outcomes. Results: A total of 63 paired samples were collected. The A-LACT and V-LACT were strongly correlated (r ¼ .934, P < .0001, r 2 ¼ .873). The regression equation was A-LACT ¼ (0.934 Â V-LACT) À 0.236. The mean difference between V-LACT and A-LACT was 0.66 + 1.53 mmol/L. The 95% limits of agreement were between À3.66 and 2.33 mmol/L. The V-LACT ! 4 mmol/L can predict A-LACT level ! 4 mmol/L with 87.5% sensitivity and 91.5% specificity, and the area under receiver operating characteristic curve was 0.948. Conclusion: The present study demonstrated a strong correlation between A-LACT and V-LACT, but an agreement between both parameters was poor. We suggest not to use the V-LACT in substitution to the A-LACT in sepsis regarding the absolute value and clearance rate, but the V-LACT ! 4.5 mmol/L may be used for predicting the A-LACT ! 4 mmol/L.
Introduction
Arterial blood lactate is known as a standard parameter of severity and prognosis of circulatory shock. It is highly correlated with the lactate measured from a blood sample of the pulmonary artery and central venous catheter representing lactate produced from all organs. 1 The arterial lactate was demonstrated to be a biomarker for sepsis in many studies. In 1991, Bakker et al showed the stronger association between lactate and mortality in sepsis compared to other parameters. 2 Another study exhibited that the duration of the arterial lactate above 2.0 mmol/L was more important than the initial lactate level. 3 The alteration of arterial lactate level within the first 24 hours of treatment was strongly associated with short-term survival in patients with septic shock. 4 Furthermore, De Backer et al exhibited the relationship between the arterial lactate and microcirculation function. 5 Also, a study conducted by Jansen et al showed a survival benefit in patients with sepsis having lactate clearance more than 20%, and this study allowed to use venous lactate for tissue perfusion monitoring. 6 The venous lactate was demonstrated as a prognostic factor of sepsis in fewer studies. It was a predictor associated with mortality among patients diagnosed infection in emergency department (ED). 7 Mikkelsen et al showed the association of serum venous lactate with mortality in severe sepsis. 8 The study by Arnold et al demonstrated the lower mortality in patients with sepsis having serum lactate clearance above 10%. 9 Many studies demonstrated a good correlation between the arterial lactate and the peripheral venous lactate. Younger et al studied mixed medical and surgical patients at EDs and found a good correlation between both parameters. 10 Lavery et al showed similar results; however, this study was conducted in trauma patients. 11 Another study by Gallagher et al researched agreement between arterial lactate and peripheral venous lactate among patients visiting the ED and also found the good correlation, but the agreement was not fine. 12 This study made a conclusion that the venous blood lactate could not be used in substitution to the arterial blood lactate in the ED due to an imperfect agreement.
The current guideline, the Surviving Sepsis Campaign (SSC) 2012, recommends using lactate to identify severe sepsis and being a guide for resuscitation. 13 The SSC does not specify to use arterial or peripheral venous blood for lactate measurement. In clinical practice, many physicians use peripheral venous lactate instead of arterial lactate to avoid arterial puncture and its complication. Because the arterial lactate is a global parameter, whereas the peripheral venous lactate is a regional parameter. Therefore, the value of both parameters should not be equivalent. Heterogeneity of blood flow distribution in sepsis should be a cause of the difference between both values. The more severe sepsis, the more heterogeneous blood flow is 14 and possibly lead to more difference between both parameters. Furthermore, the venous blood obtained by tourniquet technique may cause more local tissue ischemia and lead to higher production of local lactate level.
As a result of this, we reasoned that the peripheral venous lactate and the arterial lactate might not be used interchangeably among patients with sepsis. However, we need to prove our hypothesis scientifically by demonstrating how related they were, regarding a correlation and agreement.
Materials and Methods
We conducted an observational study and prospectively enrolled patients admitted to the medical intensive care unit in a university hospital, Bangkok, Thailand. The study was approved by the institute's Human Research Committee Institutional Review Board and followed the National Helsinki Committee guidelines. All patients or their next of kin gave written informed consent. The inclusion criteria were (1) age over 18 years old, (2) presence of sepsis or septic shock, and (3) requiring arterial lactate monitoring. The sepsis or septic shock was defined according to the criteria of SSC: International guidelines for the management of severe sepsis and septic shock: 2008. 15 We excluded patients having a contraindication to radial artery puncture, patients with 2 or more attempts of acquired venous blood, acute liver failure, and denying inform consent.
The eligible patients were drawn arterial blood and venous blood for measuring arterial lactate (A-LACT) and venous lactate (V-LACT) simultaneously whenever the lactate was required for monitoring. All arterial blood for A-LACT was drawn from an arterial catheter. The venous blood for V-LACT was drawn from a cubital vein with tourniquet technique by experienced intensive care nurses. Both specimens were collected in separate tubes containing heparin. Those tubes were instantly packed in ice bags and sent to the laboratory. Our hospital used the GEM Premier 3000 blood gas analyzer (Diamond Diagnostic Inc., Holliston, Massachusetts, USA) for the measurement of blood lactate. The measurable value is ranging from 0.3 to 25 mmol/L. The normal amount of lactate from this device is between 0.7 and 2.5 mmol/L. The tourniquet time (interval between the placement of a tourniquet and the complete venous blood drawing) before arterial or venous puncture and the elapsed time between obtaining the A-LACT and V-LACT were not recorded and adjusted in statistical analysis because the present study was designed as a pragmatic study.
The baseline characteristics were present as mean + standard deviation (SD) for scale variables and as percentage for nominal variables. We analyzed the correlation between the A-LACT and the V-LACT by Pearson correlation and portrayed as r 2 value. The P value less than .05 was reported for statistical significance. Analysis of agreement was performed with the use of the Bland-Altman plot. The difference between the A-LACT and the V-LACT was plotted against the mean of the V-LACT and the A-LACT values. We determined bias by calculating the average difference between paired variables. The fixed bias was considered if the average difference was significantly far from 0. The 95% limits of agreement were computed to determine the precision of testing variables. This was the range of the mean difference + 1.96 SD of the difference. The V-LACT would be a perfect parameter if the fixed bias is very close to 0 in combination with the differences between the A-LACT and the V-LACT within the 95% limits of an agreement must not be clinically significant. Otherwise, the V-LACT could not be used in substitution to the A-LACT.
Regarding the arterial lactate, above 4 mmol/L was associated with mortality in sepsis, 7 and this value was used as a standard parameter for a severe form of sepsis. 3 Therefore, we also analyzed the performance of the V-LACT for predicting the A-LACT ! 4 mmol/L by plotting the receiver operating characteristic (ROC) curve and calculating the area under the ROC curve. We analyzed all data by SPSS version 17.
Results
A total of 63 paired specimens from 63 participants were analyzed in the present study. The baseline characteristics are shown in Table 1 . We found severe sepsis in 34 (54%) of the total participants and septic shock in 24 (38%) of the total participants. The most common cause of sepsis was pneumonia. We found 1 patient having chronic liver disease, Child class A, before admission and contribute 1 paired samples. The mean age was 68.33 + 14.5 years. Male occupied 53.30% of all. Eighty percent of blood lactate was collected during the hypotensive state. The mean serum creatinine was 2.83 + 2.39 mg/dL. The median A-LACT and V-LACT is shown in Table 1 .
The Pearson correlation coefficient between A-LACT and V-LACT was 0.934 (r 2 ¼ .873). By linear regression analysis (Figure 1 ), the regression equation was A-LACT ¼ (0.934 Â V-LACT) À 0.236. As shown in Bland-Altman plot (Figure 2 ), the mean difference between A-LACT and V-LACT was À0.66 + 1.53 mmol/L. The limits of agreement were between À3.66 and 2.33 mmol/L. The mean difference was decreased to 0.38 + 0.79 mmol/L in a subgroup of lactate 4 mmol/L. Likewise, the limits of agreement were between À1.95 and 1.19 mmol/L (Figure 3 ). Another subgroup analysis was performed, and we categorized into initial lactate and posttreatment lactate. The initial lactate was measured in 45 participants, and the posttreatment lactate was measured in 18 participants. The correlation coefficient in the former and latter group was 0.955 (r 2 ¼ .912) and 0.905 (r 2 ¼ .82), respectively. The mean difference of initial lactate was À0.81 + 1.24 mmol/L. The limits of agreement were between À3.24 and 1.62 mmol/L. The mean difference of posttreatment lactate was À0.29 + 2.10. The limits of agreement were between À4.41 and 3.826 mmol/L. The V-LACT ! 4 mmol/L can predict A-LACT level ! 4 mmol/L with 87.5% sensitivity and 91.5% specificity. The area under the ROC curve was 0.948, as shown in Figure 4 . The best cutoff value of V-LACT for predicting the A-LACT ! 4 mmol/L was 4.5 mmol/L. The sensitivity and specificity were 87.5 and 95.7, respectively.
Discussion
According to the results of our study, the agreement between A-LACT and V-LACT makes concern in clinical practice. The difference between them is greater when the lactate level ! 4 mmol/L. This number is widely used in many studies as inclusion criteria. [16] [17] [18] [19] Thus, it may affect study outcomes. Even though the better agreement was observed in the subgroup of patients with lactate 4 mmol/L, it was not good enough to use interchangeably in clinical practice.
The Absolute Value of Peripheral Venous Lactate
We use the total amount of A-LACT as a standard parameter for the assessment of sepsis severity and prognosis. [2] [3] [4] 6 Thus, we were very concerned using the V-LACT instead of the A-LACT for this purpose. The 95% limits of agreement, À3.66 and 2.33, make the absolute value of the V-LACT too low or too high compared with the A-LACT. With unacceptable limits of agreement, using the V-LACT may provide unreliable data for physicians and cause misleading. The study by Mikkelsen et al may be an example. This study showed no difference in venous lactate level between patients with shock and non-shock sepsis, although it showed the difference in 28-day mortality between the 2 groups categorized by 3 different lactate levels (low vs medium vs high lactate). 8 We should realize that the V-LACT represents regional tissue perfusion. The severe septic shock causes maldistribution of blood flow in different organs 20 and causes the heterogeneity of microcirculation. 21 Therefore, the V-LACT, as a regional biomarker from local muscular tissue, may not a good parameter for assessing a global change.
Peripheral Venous Lactate Clearance
The changing of venous lactate is calculated from 2 absolute values of lactate at 2 time points. Consequently, due to unreliable absolute value, the peripheral venous lactate clearance used in clinical practice should also be unpredictable, especially in patients having lactate ! 4 mmol/L. The lactate clearance more than 10% to 20% is used to determine adequate tissue perfusion. 6, 12 But the limits of agreement between À3.66 and 2.33 mmol/L can make venous lactate clearance falsely above 10% or 20% and can lead to wrong management.
Limitation
We did not control the tourniquet time and elapsed time in our study because we aimed to design the present study for applying in real-life practice. This makes the value of venousarterial lactate difference at limits of agreement not similar to the previous study. 10 However, a study of Gallagher and team demonstrated tourniquet time and elapsed time had no effect on the correlation and agreement between A-LACT and V-LACT. The Bland-Altman plot in this study showed better agreement in a subgroup of patients with lactate below 4 mmol/L as well as our study. Thus, the obvious difference between A-LACT and V-LACT at lactate ! 4 mmol/L may be caused by the severity of sepsis itself, not related to tourniquet or elapsed time.
Clinical Application
It may be problematic in clinical practice if we use the V-LACT instead of the A-LACT regarding the absolute value and clearance rate. However, due to good performance, the V-LACT may have a role in predicting the severity of sepsis in ICU patients. It may be useful and feasible for physicians to identify more severe sepsis when they see a V-LACT ! 4.5 mmol/L. 
